Allosteric mechanism of quinoline inhibitors for HIV RT‐associated RNase with MD simulation and dynamics fluctuation network

The human immunodeficiency virus (HIV) is a retrovirus which infects T lymphocyte of human body and causes immunodeficiency. Reverse transcriptase inhibitors (RTIs) can inhibit some functions of RT, preventing virus synthesis (double‐stranded DNA), so that HIV virus replication can be reduced. Experimental results indicate a series of benzimidazole‐based inhibitors which target HIV RT‐associated RNase to inhibit the reverse transcription of HIV virus. However, the allosteric mechanism is still unclear. Here, molecular dynamics simulations and dynamics fluctuation network analysis were used to reveal the binding mode between the inhibitors and RT‐associated RNase. The most active molecule has more hydrophobic and electrostatic interactions than the less active inhibitor. Dynamics correlation network analysis indicates that the most active inhibitor perturbs the network of RT‐associated RNase and decreases the correlation of nodes. 3D‐QSAR model suggests that two robust and reliable models were constructed and validated by independent test set. 3D‐QSAR model also shows that bulky negatively charged or hydrophilic substituent is favorable to bioactivity. These results reveal the allosteric mechanism of quinoline inhibitors and help to improve the bioactivity.